Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety. Mahase E. BMJ 2024;386:q1692.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety. BMJ 2024;386:q1692.
PMID: 39074878